Christian Marcotulli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christian Marcotulli has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Grzybowski
Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland
1 shared publication - Antonio Di Renzo
IRCCS—Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy
1 shared publication Barbara Tomassini
Laboratory of Immunology and Signal Transduction, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
1 shared publicationCarlo Casali
Department of Medical Surgical Sciences and Biotechnologies, Polo Pontino-University of Rome "Sapienza", V. dell'Università 30, 00185, Rome, Italy
1 shared publication- Carlo Casali
Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication - Ettore Cioffi
Department of Medico-Surgical Sciences and Biotechnologies, University of Rome Sapienza, Latina, Italy
1 shared publication
Latest Publications
- Open Access
- 12 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3135
Retinal and Visual Pathways Involvement in Carriers of Friedreich’s Ataxia
Friedreich’s ataxia (FRDA) is a rare autosomal recessive neurodegenerative disorder due to the homozygous pathological expansion of guanine-adenine-adenine (GAA) triplet repeats in the first intron of the FXN gene, which encodes for the mitochondrial protein frataxin. In the visual system, the typical manifestations are ocular motility abnormality, optic neuropathy, and retinopathy. Despite the evidence of ophthalmological impairment in FRDA patients, there is a lack of information about the morpho-functional condition of the retina and of the optic pathways in healthy heterozygous carriers of Friedreich’s ataxia (C-FRDA). Ten C-FRDA subjects (providing 20 eyes) and thirty-five Controls (providing 70 eyes) underwent a complete neurological and ophthalmological examination comprehensive of functional (full-field Electroretinogram (ffERG), multifocal Electroretinogram (mfERG), Visual Evoked Potential (VEP), and Pattern Reversal Electroretinogram (PERG)) and morphological assessments (Optical Coherence Tomography, OCT) of the retina, macula, retinal ganglion cells, and visual pathways. The groups’ data were compared using a two-sample t-test. Pearson’s test was used to investigate the morpho-functional correlations. Statistically significant differences (p < 0.01) between C-FRDA and Control eyes for the values of the following parameters were found: ffERG b-wave amplitude, mfERG Response Amplitude Densities, PERG P50 implicit time and P50-N95 amplitude, VEP P100 implicit time, Retinal Nerve Fiber Layer (RNFL) Overall, and Nasal thickness. The values of the OCT macular volume were not statistically different (p > 0.01) between the two Groups. Therefore, our data suggest that, in C-FRDA, a dysfunction of retinal elements without morphological macular impairment may occur. In addition, a morphological impairment of RNFL associated with an abnormal neural conduction along the visual pathways can be also detected.
- 12 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3135
Open AccessRetinal and Visual Pathways Involvement in Carriers of Friedreich’s Ataxia
Friedreich’s ataxia (FRDA) is a rare autosomal recessive neurodegenerative disorder due to the homozygous pathological expansion of guanine-adenine-adenine (GAA) triplet repeats in the first intron of the FXN gene, which encodes for the mitochondrial protein frataxin. In the visual system, the typical manifestations are ocular motility abnormality, optic neuropathy, and retinopathy. Despite the evidence of ophthalmological impairment in FRDA patients, there is a lack of information about the morpho-functional condition of the retina and of the optic pathways in healthy heterozygous carriers of Friedreich’s ataxia (C-FRDA). Ten C-FRDA subjects (providing 20 eyes) and thirty-five Controls (providing 70 eyes) underwent a complete neurological and ophthalmological examination comprehensive of functional (full-field Electroretinogram (ffERG), multifocal Electroretinogram (mfERG), Visual Evoked Potential (VEP), and Pattern Reversal Electroretinogram (PERG)) and morphological assessments (Optical Coherence Tomography, OCT) of the retina, macula, retinal ganglion cells, and visual pathways. The groups’ data were compared using a two-sample t-test. Pearson’s test was used to investigate the morpho-functional correlations. Statistically significant differences (p < 0.01) between C-FRDA and Control eyes for the values of the following parameters were found: ffERG b-wave amplitude, mfERG Response Amplitude Densities, PERG P50 implicit time and P50-N95 amplitude, VEP P100 implicit time, Retinal Nerve Fiber Layer (RNFL) Overall, and Nasal thickness. The values of the OCT macular volume were not statistically different (p > 0.01) between the two Groups. Therefore, our data suggest that, in C-FRDA, a dysfunction of retinal elements without morphological macular impairment may occur. In addition, a morphological impairment of RNFL associated with an abnormal neural conduction along the visual pathways can be also detected.
- 30 November 2015
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (3) , 361-364
GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients
- 30 November 2015
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (3) , 361-364
GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients